نتایج جستجو برای: acute meylocytic leukemia

تعداد نتایج: 688128  

Journal: :iranian journal of blood and cancer 0
behnoush miladpour amireh nejat shokouhi abbas shirdel reza entezari heravi abdollah banihashem habibollah esmaeili

background: the frequency of the multi-drug resistance 1 (mdr1) gene c3435t polymorphism differs in various ethnical populations such as asian, african, and caucasians populations. a silent c3435t polymorphism in exon 26 of mdr1 has been reported to be associated with a decreased expression of p-gp in tt genotypes carriers compared with cc genotypes carriers. materials and methods: to evaluate ...

Journal: :iranian journal of public health 0
raida s yahya children hospital, faculty of medicine, mansoura university, mansoura, egypt manal i fouda dept. of clinical pathology, faculty of medicine, mansoura university, mansoura, egypt hatim a el-baz dept. of biochemistry, national research center, cairo, egypt tamer e mosa dept. of biochemistry, national research center, cairo, egypt mohamed d abd elmaksoud dept. of biochemistry, national research center, cairo, egypt

background: the aim of this study was to detect the prognostic significance of survivin level and the expression of total p53 in acute lymphoblastic leukemia (all) and its correlation to patients' outcome. methods: sixty two children newly diagnosed with acute lymphoblastic leukemia were treated with chemotherapy and followed up for 2 years or until death. twenty apparently healthy volunteers w...

Journal: :international journal of hematology-oncology and stem cell research 0
atieh modaressi faculty of pharmacy, and research center for rational use of drugs, tehran university of medical sciences, tehran, iran. molouk hadjibabaie faculty of pharmacy, and research center for rational use of drugs, tehran university of medical sciences, tehran, iran. ahmadreza shamshiri department of epidemiology, hematology-oncology and bmt research center/tehran university of medical sciences, tehran, iran. rocsanna namdar faculty of pharmacy, department of clinical pharmacy, university of colorado, denver. mohammad abdollahi faculty of pharmacy, and pharmaceutical sciences research center, tehran university of medical sciences, tehran, iran. ardeshir ghavamzadeh hematology-oncology and sct research center, department of hematology-oncology, shariati hospital, tehran university of medical sciences, tehran, iran.

objective: this study was conducted to evaluate serum trace elements level, selenium (se), zinc (zn), and copper (cu) at the diagnosis of acute leukemia, and also if there is any difference in their serum levels among various subtypes of disease. subjects: fifty newly-diagnosed acute leukemia patients before starting therapy and fifty healthy subjects were entered into the study. methods: serum...

Journal: :iranian journal of pharmaceutical research 0
mahmoud ebrahimi atherosclerosis research center, imam reza teaching hospital, school of medicine, mashhad university of medical sciences, mashhad, iran abolghasem allahyari department of hematology, imam reza teaching hospital, school of medicine, mashhad university of medical sciences, mashhad, iran mohsen ebrahimi department of emergency medicine, imam reza teaching hospital, school of medicine, mashhad university of medical sciences, mashhad, iran hesam mostafavi-toroghi biochemistry of nutrition research center, school of medicine, mashhad university of medical sciences, mashhad, iran golkoo hosseini biochemistry of nutrition research center, school of medicine, mashhad university of medical sciences, mashhad, iran mohammad karimi mashhad university of medical sciences, mashhad, iran

we aimed to investigate the effects of dietary combination of honey and ardeh on chemotherapy-induced complications in patients with acute myeloid leukemia (aml).a total of 107 aml patients who underwent chemotherapy for at least 30 consecutive days were recruited to this double-blind randomized placebo-controlled clinical-trial which was conducted in the imam reza and ghaem teaching hospitals ...

Journal: :avicenna journal of medical biotechnology 0

in many acute leukemias, normal differentiation does not occur. however, in many cell lines derived from hematologic malignancies, differentiation or apoptosis can be induced by variety of agents. despite advances in the treatment of acute lymphoblastic leukemia (all), in most patients long-term survival rates remain unsatisfactory, especially in t-cell derived all. thus we studied the anti-can...

Journal: :international journal of hematology-oncology and stem cell research 0
nasrin alizad ghandforoush msc, department of hematology, school of allied medical sciences, tehran university of medical sciences, tehran, iran bahram chahardouli assistant professor, hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran shahrbano rostami assistant professor, hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran habibeh ghadimi msc student, hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ali ghasemi phd student of hematology, blood transfusion research center, high institute for research and education in transfusion medicine, tehran, iran kamran alimoghaddam professor, hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

background: minimal residual disease (mrd) tests provide early identification of hematologic relapse and timely management of acute myeloid leukemia (aml) patients. approximately, 50% of aml patients do not have clonal chromosomal aberrations and categorize as a cytogenetically normal acute myeloid leukemia (cn-aml). about 60% of adult cn-aml has a mutation in exon 12 of npm1 gene. this mutatio...

Journal: :international journal of hematology-oncology and stem cell research 0
aireza abdollahi associate professor of pathology, department of pathology, school of medicine, imam hospital complex, tehran university of medical sciences, tehran, iran faezsh hakimi department of pathology, imam hospital complex, tehran university of medical sciences, tehran, iran mahsa doomanlou msc in microbiology,central laboratory,imam hospital complex, tehran university of medical sciences, tehran, iran azadeh azadegan msc in laboratory medicine, central laboratory, imam hospital complex, tehran university of medical sciences, tehran, iran

introduction: preventing and starting early treatment of infections in patients whose immunity system is weak due to malignancies like leukemia can reduce mortality. this study aimed to determine microbial and antibiotic resistance patterns in clinical samples of patients with acute leukemia to start early treatment before the results of clinical tests are known. subjects and methods: in this c...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: acute myelogenous leukemia (aml) is a clonal  malignant disease of hematopoietic tissue. the early use of  hematopoietic stem cell transplantation (hsct) for aml was for patients with advanced stages of disease, usually while in relapse, in second or subsequent remission, or with resistant disease. patients and methods: from march 1991 until february 2008, 356(65%) registered allo...

Journal: :international journal of hematology-oncology and stem cell research 0
ar ardjmand hematology oncology & b.m.t research center, tehran university of medical science, tehran, iran k alimoghadam hematology oncology & b.m.t research center, tehran university of medical science, tehran, iran s kaviani hematology dep., faculty of medicine, tarbiat modares university, tehran-iran a ghavamzadeh hematology oncology & b.m.t research center, tehran university of medical science, tehran, iran m djahani hematology oncology & b.m.t research center, tehran university of medical science, tehran, iran l moezzi hematology oncology & b.m.t research center, tehran university of medical science, tehran, iran

arsenic trioxide (ato) has been reported to induce apoptosis in leukemic cells of acute promyelo-cytic leukemia (apl) patients through different pathways. however, the exact mechanism of ato-induced apoptosis is not yet clear. co stimulation of death receptors cd30 and tumor necrosis factor receptor type one (tnfr-i) is one of the postulated mechanisms.in the present study we aimed to evaluate ...

Journal: :vaccine research 0
maryam nourizadeh immunology, asthma and allergy research institute, tehran university of medical sciences, tehran, iran jamshid hadjati department of immunology, school of medicine, tehran university of medical sciences, tehran, iran

acute myeloid leukemia (aml) is a type of poor prognosis hematological malignancies characterized by heterogeneous clonal expansion of myeloid progenitors. leukemic stem cells are thought to form the majority of a cell population in minimal residual diseases (mrds) which are resistant to current chemotherapeutic regimens and mediate disease relapse. current therapeutic vaccine strategies have d...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید